RICHARD BOWLING: Open Payments
NPI 1114007085 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,976 in 87 payments from 21 companies in 2025. Trend: 2023 $1,526 · 2024 $1,978 · 2025 $1,976
Food & beverage: $1,881Education: $65Long term medical supply or device loan: $30
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $335 |
| Novo Nordisk Inc | 10 | $246 |
| GlaxoSmithKline, LLC. | 9 | $213 |
| Lilly USA, LLC | 8 | $187 |
| PFIZER INC. | 7 | $169 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $157 |
| Intra-Sana Laboratories | 4 | $90 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $88 |
| Phathom Pharmaceuticals, Inc. | 7 | $88 |
| VERTEX PHARMACEUTICALS INCORPORATED | 4 | $87 |
Products named: MOUNJARO, TRELEGY ELLIPTA, AIRSUPRA, JARDIANCE, Ozempic, RELTONE 200 MG, CAPLYTA, VOQUEZNA.
Industry payments across CA — which companies pay providers there.
